Surgery vs. ozempic: which saves more muscle?
NCT ID NCT07115069
Summary
This study aims to compare two major weight loss treatments—new injectable medications (like Ozempic or Mounjaro) and gastric bypass surgery—to see how they differently affect the body. Researchers will follow 60 adults with severe obesity for one year, using body scans to measure changes in fat and muscle, and surveys to track side effects like nausea. The goal is to help doctors and patients better understand the trade-offs of each treatment option.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Vanderbilt University Medical Center
RECRUITINGNashville, Tennessee, 37232, United States
Conditions
Explore the condition pages connected to this study.